ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Season’s Greetings from the Cancer Letter

December 17, 1999

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

Interview with Claudia Henschke: Observational Study Of Spiral CT Should Change Medical Practice, She Says.

November 3, 2006

Univ. Of Pittsburg distances Itself From Fisher

June 24, 1994

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

September 23, 2011